Cargando…
Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review
Erectile dysfunction (ED) is a common and debilitating disorder seen in over 50% of men older than 70 years. Oral phosphodiesterase type 5 (PDE5) inhibitors are the mainstay of treatment for ED, but cannot be used by a significant subset of patients due to systemic side effects and drug–drug interac...
Autores principales: | Anaissie, James, Hellstrom, Wayne JG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977016/ https://www.ncbi.nlm.nih.gov/pubmed/27536559 http://dx.doi.org/10.2147/RRU.S68560 |
Ejemplares similares
-
Modifying Risk Factors in the Management of Erectile Dysfunction: A Review
por: DeLay, Kenneth J, et al.
Publicado: (2016) -
Reviewing the evidence for shockwave- and cell-based regenerative therapies in the treatment of erectile dysfunction
por: Drury, Robert, et al.
Publicado: (2021) -
Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility
por: Katz, Eric G, et al.
Publicado: (2014) -
Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017) -
The dangers of sexual enhancement supplements and counterfeit drugs to “treat” erectile dysfunction
por: Chiang, Jason, et al.
Publicado: (2017)